DCT and melanoma: A mouse B16-F10 melanoma metastasis model was immunized with CC-SnT-TRP2 OMVs, and we compared this to treatment with free SnT-TRP2, CN OMVs, or a mixture of SnT-TRP2 and CN OMVs (Fig. 4a).